Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-20-031895

Director bought 10,000 shares at $0.78 ($7,800)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
DIGIANDOMENICO ANTHONY Director 2020-05-22 Purchase +10,000 $0.78 $7,800 252,083 D: show line 1 in the form
Open-market purchases · 10,000 sh · avg $0.78 · $7,800
Loading xslF345X03/doc4.xml…